Dudediligence.

BioNTech SE

BNTXNASDAQ
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$428.6M

7 notices · 4,112,088 sh

Oct 2025 to Oct 2026

Reported ·

$5,528,000

1 sale · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

The one reported sale carries the 10b5-1 box. It is 0.02% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-03: Medine GmbH, Form 1442026-05-13: Medine GmbH, Form 1442026-03-11: Poetting Sierk, Form 1442026-02-12: Medine GmbH, Form 1442025-11-28: Tureci Ozlem, Form 1442025-11-13: Medine GmbH, Form 1442025-11-05: Jeggle Helmut Wolfgang, Form 1442026-04-22: Poetting Sierk, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-03Medine GmbH, Officer, 10% Stockholder$89.1M
858,209 shno plan dateForm 4s on file end Jun 23144 ↗
2026-05-13Medine GmbH, Officer, 10% Stockholder$80.4M
858,209 shno plan dateForm 4s on file end Jun 23144 ↗
2026-03-11Poetting Sierk, Chief Operating Officer$12.6M
150,000 sh10b5-1 plan144 ↗
Form 4, 2026-04-23: sold 50,000 at $110.56 Form 4 ↗
2026-02-12Medine GmbH, Officer, 10% Stockholder$93.9M
858,209 shno plan dateno Form 4 on file144 ↗
2025-11-28Tureci Ozlem, Chief Medical Officer$12.7M
123,331 shno plan dateno Form 4 on file144 ↗
2025-11-13Medine GmbH, Officer, 10% Stockholder$124.4M
1,114,130 shno plan dateno Form 4 on file144 ↗
2025-11-05Jeggle Helmut Wolfgang, Director$15.5M
150,000 shno plan dateno Form 4 on file144 ↗